News

Drug in Ozempic may enable patients with newly diagnosed type 1 diabetes to stave off insulin use, small study suggests

todaySeptember 8, 2023 1

share close
Drug in Ozempic may enable patients with newly diagnosed type 1 diabetes to stave off insulin use, small study suggests
A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three to six months in a small study.

​ A weekly dose of semaglutide, the key ingredient in blockbuster medications Ozempic and Wegovy, helped seven out of 10 patients newly diagnosed with type 1 diabetes stop taking insulin after three to six months in a small study. Read More Breaking News, Latest News and Videos | CNN 

Written by:

Rate it
0%